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It is important to have an accurate model for calculating limits to sperm donation so as to avoid inadvertent half-
sibling mating and help protect the rights and welfare of the donor- inseminated child. The most highly developed
model to date cannot be used as there is inadequate regulation of donor insemination among United States sperm
banks. (Fertil Steril 2009;-:-–-. 2009 by American Society for Reproductive Medicine.)Internationally, there is much divergent opinion concerning
how assisted reproductive technology (ART) practices should
be supervised (1) and, as stated in the International Federa-
tion of Fertility Societies (IFFS) Surveillance 2007 (1), coun-
tries govern their ART practices by using either legislation
(hereafter referred to as regulation) or guidelines. One tech-
nique used in ART is donor insemination (DI), which brings
together four main stakeholders: ART providers, gamete do-
nors, recipient parents and DI offspring (2). Regarding the su-
pervision of DI, there are a number of issues that affect all or
some of these stakeholders, including: the degree of donor
anonymity (2–6); the degree of, and differentiation between,
screening and testing of potential donors (7); the number of
families to whom any one donor can provide gametes (8,
9); the effect of payment for sperm (10–15); and the eligibil-
ity criteria for donor insemination (1). This paper discusses
the important distinction between regulation and guidelines
in regard to ART supervision, the advantages and disadvan-
tages of regulation, and the need for greater regulation in
the United States to safeguard the rights and welfare of the
DI child. The author maintains that the establishing of a man-
datory federal donor registry, as recommended by Cahn (16),
would benefit the welfare of the DI child by enabling the im-
plementation of an updated model to assist policy makers in
setting sperm donor limits to reduce the risk of half-sibling
mating resulting from the multiple use of sperm donors in
DI treatment (8, 17). A federally mandated donor registry
would allow agencies to [1] centrally record the location
and number of DI children each donor fathers, [2] keep track
of sperm donor identity and thus help prevent multiple dona-
tions across clinics, and [3] monitor donor medical history.REGULATION VERSUS GUIDELINES
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followed (1, 4, 16, 18). This distinction is the primary advan-
tage of regulation over guidelines in this context. Anecdotal
evidence suggests that, in the United States, where governing
is by guidelines, violation of some aspects may be wide-
spread (1). The IFFS Surveillance 2007 report (1) indicated
that there is evidence that guidelines regarding the number
of embryos to be transferred are not being heeded. This
was evident, at the time, by the ongoing high rate of multiple
births. It is well documented that there are serious conse-
quences, for both mother and child, associated with multiple
births (19, 20). If this guideline—which addresses a practice
with such serious consequences—was being violated, then
what other guidelines—which have less immediate or obvi-
ous ramifications—are not being heeded? Specifically re-
garding DI, there has been concern raised about the
observance of guidelines relating to donor screening for DI
(4, 20–23). Further, there is anecdotal evidence suggesting
that guidelines, regarding donor limits (24, 25) and the keep-
ing of records that would enable families to access donor in-
formation for medical purposes, are not being followed (4,
16, 21–27). In addition, there is evidence to suggest that
even mandated U.S. Food and Drug Administration (FDA)
regulations are not necessarily followed by at least some
agencies or clinics. This was evident when the Centers for
Disease Control and Prevention (CDC) contracted out the
collection of data on ART procedures performed in 2004
(19), and it was discovered that 11% of ART medical centers
did not report their 2004 data, despite the federal mandate
(28). This raises the question that, if mandated FDA regula-
tions are not always being followed, how likely is it then
that voluntary guidelines are also not being heeded?
Currently in the Unites States, there are actually few fed-
eral regulations that require the DI industry to consider the
best interests and rights of the children they help to create
(2, 4, 15, 16, 29). The FDA oversees the laws regarding the
safety of gamete handling and the minimum requirements
for screening and testing of donors (7); however, although
it mandates the reporting of ART success rates (16, 19, 30)
it does not require records be kept regarding DI or the report-
ing of DI success rates (16, 31, 32). This is one reason why
there is a call for the establishing of a mandatory nationalFertility and Sterility Vol.-, No.-,- 2009 1
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would record the identity of all donors and DI success rates
and thus assist authorities in monitoring and tracking gamete
donation across the country. This would detect, among other
things, whether a donor was providing gametes to numerous
banks and potentially numerous families across multiple
jurisdictions.
There are disadvantages, however, to regulating ART prac-
tices. For example, ART regulation that specifically relates to
restrictions on eligibility criteria, such as in countries that do
not make ART available to single women or lesbian couples,
can lead to reproductive tourism (1, 34–36). In addition, reg-
ulation regarding the revocation of donor anonymity in DI (2,
4, 36–38) can lead to a reduction in available donors (1, 4, 12,
16, 39). In countries where both or either of these regulations
are in place, they are designed, in part, to safeguard the rights
and welfare of the DI child (4, 40–42). These regulations can,
on the other hand, potentially disadvantage the clinics and
gamete providers (4, 39), and possibly the potential parents,
if they are not eligible for DI treatment or have to wait for
a donor to become available (11, 16, 43). The eligibility issue
is not relevant to the Unites States, however, and approxi-
mately 50% of DI customers are currently single women or
lesbian couples (4).
Considering the advantages and disadvantages of regula-
tion, the author suggests that adequate regulation of DI could
perhaps be defined as regulation that first safeguards the in-
terests and rights of the DI child in regard to their physical,
mental, and emotional well being, accounting for any risk
to the child, including that of inherited disorders and psycho-
logical damage (1, 40, 44, 45); second, it considers the rights
and welfare of the recipient parents and gamete donors (46).
There are many who are of the opinion that the rights and best
interest of the DI child should be the most important consid-
eration in the ART process, and that the rights of no other
stake holder should have precedent over that of the resultant
child (4, 40, 44, 47–51). This view is in keeping with the
United Nations Convention on the Rights of the Child (52).
The success of regulation in other countries can perhaps
only be assessed by first considering what constitutes suc-
cess. If the rights and welfare of all stakeholders have been
considered under the regulation, and the welfare of the DI
child has been the primary consideration, then perhaps suc-
cess could be said to have been achieved (16). This can pos-
sibly be gauged by which of the four primary stakeholders—
ART providers, gamete donors, recipient parents, or adult
offspring—are voicing the most dissent. If the dissension is
primarily from the ART providers, as in the United Kingdom
(47) and other countries where anonymity has been revoked
(1, 53), then perhaps some success has been achieved. If dis-
sension, however, is from those advocating the rights and
welfare of DI children (4, 21, 33, 40, 44, 45, 49, 51) and an-
ecdotally, from DI children and their parents (24, 25, 54–
56)—as is currently the case in the United States—perhaps
further investigation, as is recommended in this paper, should
be undertaken to establish what processes can be imple-2 Sawyer Keeping count: it’s a relative mattermented to more fully meet the interests of the increasing
number of DI offspring and their families. There are many ad-
vocates, in the United States and elsewhere, either requesting
or advising for more regulation of DI because they believe
that the current system is inadequate and not properly pro-
tecting the rights and welfare of DI offspring (2, 4, 16, 21,
57–59).ANONYMITY
As previously mentioned, the revocation of anonymity in
Europe and the United Kingdom has resulted in a consider-
able decrease in the number of donors (1), and U.S. sperm
banks insist that it would devastate the U.S. industry to have
mandatory identity disclosure (32). Thus, sperm banks rou-
tinely turn down offspring asking for donor identities (25),
although pressure from single women and lesbian couples
has led some banks in the United States to establish ‘‘iden-
tification consent’’ donor programs (54) and ‘‘open donor’’
lists that offer more money to men willing to be identified.
Donor anonymity is a controversial issue (4, 16, 32), and
the revocation of donor anonymity has resulted in reduced
availability of gamete donors in some countries (1, 4, 10,
12, 16, 39), many still think that availability of donors is
not as important as the rights of the DI child to have access
to information about their genetic heritage (4, 16, 40, 44,
50, 51). Although it is true that there is a natural social
problem relating to unknown paternity, Sylvester suggests
that it is unethical to create a situation that results in un-
known paternity by deliberately creating children who can
never know their biological origins (4). Currently in the
United States, there are no reliable records kept regarding
the number of DI children (16) or the number of children
who do not know the identity of their biological father
(60). Thus, there are no statistics available to compare the
number of DI children who don’t know the identity of their
biological father to other children with unknown paternity.GENETIC HERITAGE
There is anecdotal evidence suggesting that DI children are
actually more interested in their genetic heritage than in iden-
tifying and having an on-going relationship with their donor
father (54). In recent years, the World Wide Web has made it
possible for DI offspring to trace information about their do-
nor father and DI half-siblings through the matching of donor
identification numbers (24). Although these DI offspring are
not necessarily making contact with their donor fathers, half-
siblings are establishing contact with each other, and a new
form of extended biological family is evolving (25, 56). Hav-
ing knowledge of the genetic heritage or genotype that an in-
dividual inherits from their parents (33, 49, 58, 61–67) is an
important concern for many DI children (29, 49). Genetic
heritage determines an individual’s hereditary potentials
and limitations (66), and it is well documented that although
the environment strongly influences the physical, mental, and
emotional development of an individual (68, 69), so do the
genes inherited from both mother and father (61). IllnessesVol.-, No.-,- 2009
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emotional stress, anger, or depression is experienced (61, 70).
Significantly, medical genetics has become an integral part of
preventive medicine (67). Knowledge of genetic makeup al-
lows humans to understand why they are the way they are,
helps provide a sense of identity, and allows people to com-
prehend their potential strengths and limitations (4, 29, 40,
41, 49). The importance of knowing one’s genetic heritage
or makeup is asserted by the ethics committee of the Ameri-
can Society for Reproductive Medicine, which noted that
‘‘with respect to disclosure: clinicians, mental health profes-
sionals, academics, and children themselves have in recent
years called for more openness in donor conception in order
to protect the interests of offspring. Because of persons’ fun-
damental interest in knowing their genetic heritage and the
importance of their ability to make [informed health case de-
cisions in the future] the Ethics Committee supports disclo-
sure about the fact of donation to children. It also supports
the [gathering and storage of medical and genetic informa-
tion] that can be provided to offspring if they ask’’ (33).
The establishing of a national donor register would enable
the closer monitoring, reporting, and matching of all DI births
and donors across the country and enable DI children to have
access to information regarding their genetic heritage. This
could be facilitated without the need to disclose identifying
information (4, 16).GENETIC DISEASE
The use of donor sperm has made it possible for relatively rare
genetic diseases to affect many more families than before DI
was used (16). In addition, there is evidence to suggest that
there is ongoing concern from DI clients and health industry
authorities concerning the spread of undetected genetic dis-
ease (16). Although the FDA requires donor agencies to
screen for several communicable diseases (including HIV)
and some genetic disorders, DI practitioners must gain per-
mission from the donor to test beyond the common genetic
disorders and are not obliged to inform new clients of health
problems among a donor’s previous children (4, 22, 23).
Agencies are permitted to [1] set their own limits on donor
use, [2] rely on the donors to accurately relay information
about their family medical history and important genetic in-
formation (7), and [3] provide whatever remuneration they
deem appropriate. Although many providers claim that ano-
nymity is best for all parties (25), critics maintain that the in-
dustry’s preference for anonymity allows it to escape
accountability and to avoid imposing limits on popular donors
(16, 32). There is also concern regarding the fact that ‘‘dona-
tion’’ implies that there is no payment (14, 16, 39, 71) and that
compensation could entice men to potentially falsify or with-
hold information and thereby exploit recipient families (14–
16, 72). This further underscores the need for centralized reg-
ulation and monitoring. At the very least, the number of DI
children fathered by a given donor should be recorded in a na-
tional database, which would then enable the potential spread
of genetic disease to be monitored. A national donor registryFertility and Sterilitywould also assist in the calculation of variable values for use in
an up-to-date model that predicts the possible number of half-
sibling matings resulting from the multiple use of sperm do-
nors in a given location. This information could then assist
policy makers in setting limits on donor use to reduce the
risk of half-sibling mating and the associated possibility of ge-
netic abnormalities in their offspring (8, 17, 73, 74).HALF-SIBLING MATING
The potential number of half-sibling matings resulting from
the multiple use of sperm donors has been difficult to esti-
mate, because exact numbers of offspring born as a result
of DI are unknown (32). In 1980, Curie-Cohen developed
a model to predict the number of half-sibling matings likely
to occur, per year, as a result of multiple use of sperm donors
in the United States (8). The model required values for the
number of sperm donors used in a given location, the average
number of possible half-sibling matings per donor and the
probability that a pair of half-siblings will mate. This knowl-
edge was then intended for use in the setting of an optimal or
maximum number of children per sperm donor for any state,
or designated region, within the United States (8). Because
the data used for the model were drawn from the late 1950s
through to the late 1970s, the demographic variable values
have changed (75–80), as have the cohort seeking and access-
ing DI treatment (26, 81–83) and donor profiles (2, 13, 47).
Therefore, the author’s recent attempt to predict the number
of half-sibling mating for the present day in the United States
has been frustrated because of difficulties in implementing
Curie-Cohen’s 1980 model. The accuracy of the model has
been weakened by [1] changes in the DI industry and [2]
changes in population demographics.
Firstly, and most significantly, the commercialization of
sperm banks has contributed to the inadequate monitoring
and reporting of DI births (4, 16, 21, 57, 58) with subse-
quent difficulties in tracking both the geographic location
and the number of DI children per donor (25, 32). In
1989 there were approximately 135 banks across the United
States, but as a result of commercialization and the soaring
costs associated with donor recruitment and screening, in
2001 there were only 28 banks left—in just 16 states
(32). Seven of those were in California, three in New
York, three in Minnesota, and 15 were scattered across other
states with approximately half (46%) of all donor sperm
coming from the five biggest banks. It is reported that there
are currently 25 sperm banks across the United States that
have, in total, approximately 1,630 registered donors (31).
Therefore, a woman, with assistance from her physician,
can now choose and order donor sperm on-line from a large
sperm bank and have it shipped across the country (32, 84).
This has significant ramifications for the calculation of vari-
able values in Curie-Cohen’s model.
Secondly, the establishing of large centralized sperm banks
has led to the probability of a DI child being born in the same
state as a half-sibling to become much less likely. In addition,3
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Cohen’s model—is impossible to determine because of
sperm being shipped across state borders. A donor’s DI
children are now less likely to be born or married in the
same state as his natural children or as each other. There is
evidence to suggest that the degree of national migration
has changed, with the level of migration of donors and recip-
ient families (76, 77, 80, 85) having dropped since the early
1980s and is ultimately, as with the DI children themselves,
continuing to do so (80, 86–91). In addition, because of an in-
crease in the number of children being born outside of formal
marriage arrangements (31, 32, 92) the use of marriage data
for determining variable values is no longer valid and the
calculation of the proportion of marriages between people
born in the same state is no longer relevant. Accordingly,
a different means for estimating assortive mating for geogra-
phy will need to be developed and will undoubtedly alter the
calculated number of possible half-sibling matings resulting
from DI. A new, updated model can only be developed and
be of use when there is adequate reporting and recording of
vital statistics, such as the number and location of DI births
(4, 16, 21) and number of DI children per donor. This record-
ing would be facilitated by a nationally mandated donor
registry.
A centralized registry would also enable the calculation of
the average number of possible half-sibling matings per do-
nor—another crucial variable in Curie-Cohen’s model—
and the average number of DI children per donor (93) could
then be computed. It is reported that, in 1990, there were
20,000 DI births in the United States (81). In addition, there
are reports that the number of donor-conceived offspring is
increasing, with numbers still estimated to be between
30,000–60,000 (16, 26, 82). Informal guidelines from the
American Society for Reproductive Medicine on donor limits
currently recommend no more than 20 births per donor for
a region of 800,000 people (7). However, one bank appar-
ently allows up to 52 children per donor, and the national av-
erage is thought to be between 20 and 30 (22). As already
mentioned, there is a federal mandate to record success rates
for ART by recording all live births per ovarian stimulation
procedure (19). There are, however, no records kept that track
DI success rates, and adherence to guidelines for limiting off-
spring is voluntary (16, 31, 32). In addition, as women are not
required to report DI births it is quite likely that many donors
could have over 30 children. Therefore, in the absence of any
centralized records (4, 16, 21, 27), the number of children
born each year as a result of DI and the identity their donors,
cannot be reliably established (16).
Therefore, the need to establish a federal donor registry to
monitor the numbers and location of donors and their DI off-
spring is fundamentally linked to regulation that will protect
the rights and welfare of the DI child is. This registry will en-
able the development of an updated model to determine the
probability of half-sibling mating and protect DI children
from accidentally forming incestuous relationships (4, 16,
17).4 Sawyer Keeping count: it’s a relative matterDISCUSSION AND RECOMMENDATIONS
Currently in the Unites States there are voluntary guidelines,
but no regulations that set limits to the use of donor sperm
(16). The DI industry appears to operate as a commercial,
for-profit industry that is primarily focused on treating adult
infertility and does not view the rights and welfare of the DI
offspring as the most important consideration in the DI pro-
cess (4). It is true that there are many clinicians who are con-
cerned about the welfare of all their clients (46), but generally
in the United States, the DI industry appears to put the rights
of the donor to remain anonymous and the desires of infertile
couples above the rights and welfare of the DI offspring (4,
16, 20, 21, 32, 57). Certainly, changes in recommendations
regarding management of DI continue to be made, but
whether changes in recommendations are likely to be heeded
and what agency monitors this is open to question (1, 19).
There is a call for the mandatory reporting and recording of
all donors and their DI offspring in a centralized register. This
call comes from those who are concerned with the rights and
welfare of DI children (4, 16, 21, 94) as well as from the pop-
ular media. Anecdotal evidence through the media primarily
comes from advocacy groups (24) and individuals concerned
with having access to information about their genetic heritage
and knowledge about potential half-siblings (22, 24, 25, 31,
54, 55).
It is acknowledged that the establishing of a national donor
registry would be complex given the Health Insurance Porta-
bility and Accountability Act (HIPAA) in the United States
(95) and that a donor registry could not be enforced retrospec-
tively. Consequently, it would apply to future donors—possi-
bly recruited by different means (10, 11, 15, 43) and donating
for different reason (13, 47, 96)—and future recipient parents
and offspring who would be encouraged to increasingly re-
gard openness about genetic origins to be the norm (3, 40,
44, 48–50, 62, 97–101), as is currently the case with adoption
(16).
The author recommends that a nationally mandated regis-
try of donors and donor offspring be established. The purpose
of this registry is fourfold: [1] that donors will be prevented
for making multiple, untracked donations in different loca-
tions (16), [2] that comprehensive health and genetic infor-
mation can be available before sperm is offered for sale
(23), [3] that women can be informed as to how many chil-
dren a donor has, and in what location (31); and [4] that an
industry ethics code guarantees that DI children will have ac-
cess to knowledge about their genetic heritage (25). In addi-
tion, the author recommends that the increasingly urgent and
significant legal and ethical challenges (4, 16, 102) regarding
sperm donor anonymity, disclosure and the setting of sperm
donor limits continue to be investigated. There is an increas-
ing awareness that genetic information is important to the es-
tablishment of identity for the DI child and in preventative
medicine (4, 67), as well as an increasing ability for DI chil-
dren to independently discover the identity of their donor
through genetic data bases and the Internet. There is alsoVol.-, No.-,- 2009
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sure of DI origins serve the best interest of the DI child
(33, 40, 44, 48, 62), and there is the need to provide policy
makers with criteria for setting sperm donor limits, to moni-
tor the possible number of half-sibling matings that could re-
sult from the multiple use of sperm donors (8, 17, 103, 104).CONCLUSION
The establishing of a mandatory donor gamete registry would
assist in the creation of an updated model for predicting the
number of half-sibling matings that could result from the
multiple use of donors in DI. Currently, there are difficulties
in calculating the values for variables used in Curie-Cohen’s
model. However, improved reporting and recording of donor
identities and DI births in a national registry would generate
data that [1] would reflect changing reproductive trends and
social conditions and [2] can be used in an updated model
for use as a tool by policy makers to establish donor limits
in any given location (17).
Regulation does not solve all problems, and to require reg-
ulation only to facilitate the updating of Curie-Cohen’s model
would not be justified. Minimizing the risk of half-sibling
mating is valuable, but is only one of the reasons why a na-
tional donor registry is important (16). There is an equally
important consideration: the right of the DI offspring to
have access to information about their genetic heritage and
the medical history of their donor (33, 48–50, 57, 58, 62–
64, 105, 106). Mandatory reporting of the number DI births,
how many children an individual donor has fathered, and the
identity and profile of every donor with updated medical re-
cords (18) would make possible the recording of information
that could assist agencies in keeping track of children born
through gamete donation and enable them to provide DI off-
spring with important genetic information (4, 16).
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